Shukui Qin

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Liwei Wang · 2 shared papers, 2024–2026 · strength 0.37
   • Paper Chinese expert consensus on precision testing and molecular diagnosis of pancreatic cancer (2025). DOI 10.1038/s41416-026-03522-x↗
   • Paper Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or met… DOI 10.1038/s41392-024-01948-4↗
2. Jiujie Cui · 2 shared papers, 2024–2026 · strength 0.37
   • Paper Chinese expert consensus on precision testing and molecular diagnosis of pancreatic cancer (2025). DOI 10.1038/s41416-026-03522-x↗
   • Paper Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or met… DOI 10.1038/s41392-024-01948-4↗
3. Chunyi Hao · 2 shared papers, 2023–2026 · strength 0.36
   • Paper Chinese expert consensus on precision testing and molecular diagnosis of pancreatic cancer (2025). DOI 10.1038/s41416-026-03522-x↗
   • Paper Nimotuzumab Plus Gemcitabine for K-Ras Wild-Type Locally Advanced or Metastatic Pancreatic Cancer. DOI 10.1200/jco.22.02630↗
4. Wei Li · 1 shared paper, 2026 · strength 0.23
   • Paper Chinese expert consensus on precision testing and molecular diagnosis of pancreatic cancer (2025). DOI 10.1038/s41416-026-03522-x↗
5. Haitao Zhang · 1 shared paper, 2026 · strength 0.23
   • Paper Chinese expert consensus on precision testing and molecular diagnosis of pancreatic cancer (2025). DOI 10.1038/s41416-026-03522-x↗
6. Guang Tan · 1 shared paper, 2026 · strength 0.23
   • Paper Chinese expert consensus on precision testing and molecular diagnosis of pancreatic cancer (2025). DOI 10.1038/s41416-026-03522-x↗
7. Ke Cheng · 1 shared paper, 2026 · strength 0.23
   • Paper Chinese expert consensus on precision testing and molecular diagnosis of pancreatic cancer (2025). DOI 10.1038/s41416-026-03522-x↗
8. Huanji Xu · 1 shared paper, 2026 · strength 0.23
   • Paper Chinese expert consensus on precision testing and molecular diagnosis of pancreatic cancer (2025). DOI 10.1038/s41416-026-03522-x↗
9. Dan Cao · 1 shared paper, 2026 · strength 0.23
   • Paper Chinese expert consensus on precision testing and molecular diagnosis of pancreatic cancer (2025). DOI 10.1038/s41416-026-03522-x↗
10. Jianhui Wu · 1 shared paper, 2026 · strength 0.23
    • Paper Chinese expert consensus on precision testing and molecular diagnosis of pancreatic cancer (2025). DOI 10.1038/s41416-026-03522-x↗
11. Kuirong Jiang · 1 shared paper, 2026 · strength 0.23
    • Paper Chinese expert consensus on precision testing and molecular diagnosis of pancreatic cancer (2025). DOI 10.1038/s41416-026-03522-x↗
12. Qi Li · 1 shared paper, 2026 · strength 0.23
    • Paper Chinese expert consensus on precision testing and molecular diagnosis of pancreatic cancer (2025). DOI 10.1038/s41416-026-03522-x↗
13. Guanghai Dai · 1 shared paper, 2026 · strength 0.23
    • Paper Chinese expert consensus on precision testing and molecular diagnosis of pancreatic cancer (2025). DOI 10.1038/s41416-026-03522-x↗
14. Chuntao Gao · 1 shared paper, 2024 · strength 0.15
    • Paper Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or met… DOI 10.1038/s41392-024-01948-4↗
15. Jiuwei Cui · 1 shared paper, 2024 · strength 0.15
    • Paper Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or met… DOI 10.1038/s41392-024-01948-4↗
16. Jun Yao · 1 shared paper, 2024 · strength 0.15
    • Paper Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or met… DOI 10.1038/s41392-024-01948-4↗
17. Jufeng Wang · 1 shared paper, 2024 · strength 0.15
    • Paper Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or met… DOI 10.1038/s41392-024-01948-4↗
18. Zhihua Li · 1 shared paper, 2024 · strength 0.15
    • Paper Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or met… DOI 10.1038/s41392-024-01948-4↗
19. Tao Xia · 1 shared paper, 2024 · strength 0.15
    • Paper Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or met… DOI 10.1038/s41392-024-01948-4↗
20. Yuhong Zhou · 1 shared paper, 2024 · strength 0.15
    • Paper Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or met… DOI 10.1038/s41392-024-01948-4↗
21. Deliang Fu · 1 shared paper, 2024 · strength 0.15
    • Paper Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or met… DOI 10.1038/s41392-024-01948-4↗
22. Ying Yuan · 1 shared paper, 2023 · strength 0.13
    • Paper Nimotuzumab Plus Gemcitabine for K-Ras Wild-Type Locally Advanced or Metastatic Pancreatic Cancer. DOI 10.1200/jco.22.02630↗
23. Hongmei Zhang · 1 shared paper, 2023 · strength 0.13
    • Paper Nimotuzumab Plus Gemcitabine for K-Ras Wild-Type Locally Advanced or Metastatic Pancreatic Cancer. DOI 10.1200/jco.22.02630↗
24. Lin Yang · 1 shared paper, 2023 · strength 0.13
    • Paper Nimotuzumab Plus Gemcitabine for K-Ras Wild-Type Locally Advanced or Metastatic Pancreatic Cancer. DOI 10.1200/jco.22.02630↗
25. Lin Shen · 1 shared paper, 2023 · strength 0.13
    • Paper Nimotuzumab Plus Gemcitabine for K-Ras Wild-Type Locally Advanced or Metastatic Pancreatic Cancer. DOI 10.1200/jco.22.02630↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.